Beech Hill Advisors Raised By $5.82 Million Its Bristol Myers Squibb Co (BMY) Holding; Envision Healthcare Holdings (EVHC) Shorts Up By 5.26%

December 21, 2017 - By Dolores Ford

Envision Healthcare Holdings Incorporated (NYSE:EVHC) had an increase of 5.26% in short interest. EVHC’s SI was 22.07M shares in December as released by FINRA. Its up 5.26% from 20.97M shares previously. With 3.28M avg volume, 7 days are for Envision Healthcare Holdings Incorporated (NYSE:EVHC)’s short sellers to cover EVHC’s short positions. The stock increased 5.99% or $1.955 during the last trading session, reaching $34.575. About 1.92M shares traded. Envision Healthcare Corporation (NYSE:EVHC) has declined 23.31% since December 21, 2016 and is downtrending. It has underperformed by 40.01% the S&P500.

Beech Hill Advisors Inc increased Bristol Myers Squibb Co (BMY) stake by 533.82% reported in 2017Q3 SEC filing. Beech Hill Advisors Inc acquired 92,350 shares as Bristol Myers Squibb Co (BMY)’s stock declined 1.04%. The Beech Hill Advisors Inc holds 109,650 shares with $6.99 million value, up from 17,300 last quarter. Bristol Myers Squibb Co now has $100.54 billion valuation. The stock increased 0.38% or $0.23 during the last trading session, reaching $61.43. About 1.20M shares traded. Bristol-Myers Squibb Company (NYSE:BMY) has declined 23.19% since December 21, 2016 and is downtrending. It has underperformed by 39.89% the S&P500.

Envision Healthcare Corporation, through its subsidiaries, provides various healthcare services in the United States. The company has market cap of $4.13 billion. The firm operates through three reportable divisions: Physician Services, Medical Transportation, and Ambulatory Services. It currently has negative earnings. The Company’s physician-led services encompass providers at approximately 1,500 clinical departments at healthcare facilities in 45 states and the District of Columbia that include emergency department and hospitalist, anesthesiology, radiology/tele-radiology, and children's services.

Among 22 analysts covering Envision Healthcare Holdings (NYSE:EVHC), 16 have Buy rating, 0 Sell and 6 Hold. Therefore 73% are positive. Envision Healthcare Holdings had 75 analyst reports since August 3, 2015 according to SRatingsIntel. Cantor Fitzgerald maintained Envision Healthcare Corporation (NYSE:EVHC) on Monday, July 24 with “Buy” rating. The stock of Envision Healthcare Corporation (NYSE:EVHC) earned “Buy” rating by Robert W. Baird on Sunday, October 15. The rating was maintained by Barclays Capital with “Overweight” on Friday, October 23. The rating was maintained by Robert W. Baird on Friday, November 3 with “Outperform”. SunTrust maintained Envision Healthcare Corporation (NYSE:EVHC) on Friday, October 13 with “Buy” rating. Mizuho initiated it with “Neutral” rating and $30 target in Thursday, December 3 report. On Tuesday, December 22 the stock rating was upgraded by Citigroup to “Buy”. RBC Capital Markets maintained Envision Healthcare Corporation (NYSE:EVHC) on Thursday, January 5 with “Outperform” rating. The firm has “Neutral” rating by Mizuho given on Friday, November 17. The company was maintained on Wednesday, October 28 by Cantor Fitzgerald.

Among 19 analysts covering Bristol-Myers Squibb Company (NYSE:BMY), 6 have Buy rating, 3 Sell and 10 Hold. Therefore 32% are positive. Bristol-Myers Squibb Company had 69 analyst reports since July 28, 2015 according to SRatingsIntel. The company was maintained on Friday, October 28 by Deutsche Bank. BMO Capital Markets maintained Bristol-Myers Squibb Company (NYSE:BMY) rating on Friday, July 28. BMO Capital Markets has “Underperform” rating and $49 target. The company was maintained on Thursday, October 26 by Piper Jaffray. BMO Capital Markets maintained the shares of BMY in report on Wednesday, August 16 with “Sell” rating. The stock of Bristol-Myers Squibb Company (NYSE:BMY) earned “Buy” rating by Citigroup on Tuesday, September 20. The stock has “Buy” rating by Citigroup on Wednesday, October 25. The firm has “Hold” rating by Jefferies given on Tuesday, June 14. The company was upgraded on Monday, October 30 by SunTrust. The firm has “Buy” rating given on Friday, October 6 by UBS. The rating was maintained by BMO Capital Markets with “Market Perform” on Wednesday, April 5.